NASDAQ:PCRX

Pacira Pharmaceuticals Stock News

Healthcare > Drug Manufacturers - Specialty & Generic

Buy PCRX

*Your capital is at risk

$22.32

+0.0700 (+0.315%)

At Close: Jun 03, 2026

Contact Levi & Korsinsky by March 14, 2025 Deadline to Join Class Action Against Pacira BioSciences, Inc. (PCRX)

07:30am, Friday, 21'st Feb 2025

NEW YORK, NY / ACCESS Newswire / February 21, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal sec

PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Pacira BioSciences, Inc. to Contact the Firm Today!

07:00am, Friday, 21'st Feb 2025

NEW YORK CITY, NY / ACCESS Newswire / February 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Pa

Investors who lost money on Pacira BioSciences, Inc.(PCRX) should contact Levi & Korsinsky about pending Class Action - PCRX

05:45am, Friday, 21'st Feb 2025

NEW YORK , Feb. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Pacira BioSciences, Inc. ("Pacira" or the "Company") (NASDAQ: PCRX) of a class action securities lawsuit. CLASS DE

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 14, 2025 in Pacira BioSciences, Inc. Lawsuit - PCRX

11:45pm, Thursday, 20'th Feb 2025

NEW YORK, NY / ACCESS Newswire / February 20, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal sec

PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX

11:15pm, Thursday, 20'th Feb 2025

NEW ORLEANS, LA / ACCESS Newswire / February 20, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have unti

PCRX LAWSUIT ALERT: Levi & Korsinsky Notifies Pacira BioSciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

10:45pm, Thursday, 20'th Feb 2025

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PCRX

10:15pm, Thursday, 20'th Feb 2025

NEW YORK, NY / ACCESS Newswire / February 20, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Pacira BioSciences, Inc. (NASDAQ:PCRX) between August 2

Class Action Filed Against Pacira BioSciences, Inc. (PCRX) - March 14, 2025 Deadline to Join - Contact Levi & Korsinsky

08:00pm, Thursday, 20'th Feb 2025

Investors in Pacira BioSciences, Inc. Should Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your Rights - PCRX

05:15pm, Thursday, 20'th Feb 2025

PCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit with the Schall Law Firm

04:13pm, Thursday, 20'th Feb 2025

LOS ANGELES , Feb. 20, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Pacira BioSciences, Inc. ("Pacir

Pacira BioSciences, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – PCRX

01:27pm, Thursday, 20'th Feb 2025

NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Pacira BioSciences, Inc. (NASDAQ: PCRX).

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by